These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1406237)

  • 1. [Toxicological basis for evaluating health risk].
    Rolecki R; Dutkiewicz T; Kończalik J
    Med Pr; 1992; 43(3):173-81. PubMed ID: 1406237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
    Calabrese EJ
    Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundamental carcinogenic processes and their implications for low dose risk assessment.
    Crump KS; Hoel DG; Langley CH; Peto R
    Cancer Res; 1976 Sep; 36(9 pt.1):2973-9. PubMed ID: 975067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the national toxicology program report on carcinogens.
    Rodu B; Cole P; Mandel JS
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):186-8. PubMed ID: 22810056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Environmental mutagenesis and use of biomarkers in cancer risk prediction].
    Cuenca P; Ramírez V
    Rev Biol Trop; 2004 Sep; 52(3):585-90. PubMed ID: 17361552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calculation of the median effective dose and median effective time using a generalized model based on the Waibull distribution].
    Antomonov MIu; Bogorad VS
    Gig Sanit; 1992; (5-6):61-4. PubMed ID: 1398186
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mathematical dose-effect models in the study of carcinogenesis].
    Parfenov IuD
    Vopr Onkol; 1986; 32(1):9-22. PubMed ID: 3511610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in prediction of toxicity and risk of effects of chemical substances on public health].
    Rumiantsev GI; Novikov SM
    Gig Sanit; 1997; (6):13-8. PubMed ID: 9483844
    [No Abstract]   [Full Text] [Related]  

  • 13. A goal-oriented approach to reducing industrially related carcinogenic risks.
    Deisler PF
    Drug Metab Rev; 1982; 13(5):875-911. PubMed ID: 6754313
    [No Abstract]   [Full Text] [Related]  

  • 14. [Exposure to carcinogens in work environment today. State of the art, problems and prospects raised by the Law 626/94].
    Carnevale F; Baldasseroni A
    Med Lav; 1998; 89(2):102-9. PubMed ID: 9673099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [International-cooperative studies on carcinogenicity evaluation of environmental chemicals].
    Hayashi Y
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):579-84. PubMed ID: 3985632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various suggestions on the unification of methods for experimental substantiation of maximum permissible concentration of chemical carcinogens].
    Litvinov NN; Titova TA
    Gig Sanit; 1977 Oct; (10):69-73. PubMed ID: 598727
    [No Abstract]   [Full Text] [Related]  

  • 17. Precautionary principle for toxic chemicals - no alternative to safeguard societal benefits.
    Jostmann T
    Hum Exp Toxicol; 2007 Nov; 26(11):847-9; discussion 875-6. PubMed ID: 18042578
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologically based models for risk assessment.
    Portier CJ; Hoel DG; Kaplan NL; Kopp A
    IARC Sci Publ; 1990; (104):20-8. PubMed ID: 2228117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of carcinogenicity risks in work environment].
    Terracini B
    Med Lav; 1998; 89(2):98-101. PubMed ID: 9673098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicological evaluation of inhalation noxae: test methods, assessment of toxic action and hazard potential, threshold limit values].
    Kleinsasser N
    Laryngorhinootologie; 2004 May; 83 Suppl 1():S36-53. PubMed ID: 15118947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.